Zoledronic acid after spinal cord injury mitigates losses in proximal femoral strength independent of ambulation ability
ConclusionThese findings demonstrate that treatment with zoledronic acid in acute SCI attenuates losses in proximal femoral strength, which may reduce the risk of hip fractures across patients with varying degrees of ambulatory abilities.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research
More News: Brain | CT Scan | DEXA Scan | Neurology | Orthopaedics | Osteoporosis | PET Scan | Reclast | Spinal Cord Injury | Study | Zometa